Real World Evidence Scientific Lead

About the Role

We are an innovative global healthcare company focused on immunology, with extensions into diabetes and transplant medicine. Our teams across various countries are dedicated to delivering a best-in-class customer experience through digital innovation, artificial intelligence, and personal expertise. The Real-World Data & Evidence Science (RWD&ES) team within General Medicines Medical acts as a strategic partner, leveraging real-world data to solve business challenges. Join us in driving breakthroughs that transform lives, where deep immunoscience meets AI-powered research.

Responsibilities

• Partner with the Real-World Evidence Strategy aT1D Lead to deliver RWE value for the registration, pre-launch, and peri-launch of teplizumab in autoimmune type 1 diabetes (aT1D).
• Manage end-to-end planning, execution, and communication of real-world studies, ensuring deliverables are on time, within budget, and meet high scientific standards.
• Provide strategic scientific input across all stages of RWE studies, from conceptualization to closure, including study design, cohort construction, protocol development, data analysis, and clinical study report development.
• Collaborate with cross-functional stakeholders and internal/external experts to ensure real-world data and RWE generation align with intended regulatory, market access, or clinical uses.
• Serve as a methodological expert in designing and executing real-world study plans, addressing evidence gaps and leveraging innovative RWE designs and analytics.
• Identify and validate fit-for-purpose external data sources and collaborate with institutions/organizations.
• Develop budgets for RWE studies in collaboration with internal and external stakeholders, supporting strategic and budget planning.
• Maintain timely communication with team members, partners, and stakeholders to ensure alignment on evidence strategy, study progress, and risk mitigation.
• Support GenMed medical gaps within the Global Integrated Evidence Generation Plans (IEGP).

Qualifications

• Advanced degree in pharmaco-epidemiology, biostatistics, or Health Outcomes (PhD preferred). Business education is a plus.
• Minimum 5 years of experience in real-world evidence (RWE) generation within the pharmaceutical industry, with end-to-end leadership experience.
• Strong publication record in relevant journals.
• Experience across therapeutic areas, including transplant, diabetes, and cardiovascular.

Skills

• Soft Skills: Ability to influence and motivate teams and senior leaders; strategic thinking for innovative evidence generation; urgency, ownership, and proactive attitude.
• Technical Skills: Expertise in pharmacoepidemiology, HEOR, and RWE study design; experience with routinely collected healthcare data; end-to-end project management for real-world studies; understanding of commercial strategy; fluent English (second European language appreciated).

About Us

Sanofi is an R&D-driven, AI-powered biopharma company committed to improving lives and delivering growth. With a deep understanding of the immune system and an innovative pipeline, we invent medicines and vaccines that treat and protect millions globally. Join us in chasing the miracles of science to improve people’s lives.

Location: Morristown, NJ, Cambridge, MA